BSECompany Update4d ago · 25 Jul 2026, 03:11 pm

Attached

Dr. Lal PathLabs Ltd · 539524

✦ AI SummaryResults

Dr. Lal PathLabs Ltd has published its financial results for the quarter ended June 30, 2026, in accordance with Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Attachments (1)

📄

f2c1f8f1-81b5-4b78-89ea-52805b82eba8.pdf

pdf

Download →
View document text
July 25, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Corporate Relationship Department Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Symbol: LALPATHLAB Scrip Code: 539524 Sub: Newspaper advertisement(s) Ref: Financial Results for the Quarter ended June 30, 2026 Dear Sir/ Madam, Pursuant to Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the copy of newspaper advertisement(s) of Financial Results of the Company for the Quarter ended June 30, 2026, published in Financial Express and Jansatta on July 25, 2026. We request you to please take the same on record. Thanking You, Yours Faithfully, For Dr. Lal PathLabs Limited Vinay Gujral Company Secretary & Compliance Officer Encl.: As above Classification: Internal